Lutathera for direct patient care

Ended Awarded Last action

Contract number
36C25224N0197
Awardee
Awarding agency
Obligated
$157,041

Award facts

Contract value 100% obligated
$157,041.40 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
Set-aside
No set-aside
Competition
Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
Pricing
Firm Fixed Price
Place of performance
Millburn, NJ 07041, USA

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Supplemental Agreement for work within scope P00002 · Amend delivery end date to 30AUG24 $0
Supplemental Agreement for work within scope P00001 -$4,488
Original award $161,529

About this award

This federal contract award to Advanced Accelerator Applications USA Inc. is for the delivery of the radiopharmaceutical drug LUTATHERA for direct patient care. The contract, awarded by the Veterans Integrated Service Network (VISN) 12 of the U.S. Department of Veterans Affairs (VA), has a ceiling value of $157,041.40 and a period of performance ending on August 30, 2024. The contract was awarded on December 7, 2023 and is a Delivery Order under the Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB) contract vehicle. The contract does not have a set-aside designation. Advanced Accelerator Applications USA Inc. is the prime contractor and manufacturer of the radiopharmaceutical products, which are used for the treatment of neuroendocrine tumors and other medical applications at VA medical facilities.

Quick answers

Who was awarded contract 36C25224N0197?

36C25224N0197 was awarded to Advanced Accelerator Applications USA Inc. by Veterans Integrated Service Network 12 (Veterans Health Administration) on December 7, 2023.

How much is contract 36C25224N0197 worth?

The government has obligated $157,041 on 36C25224N0197.

Is contract 36C25224N0197 an order under another contract?

Yes. 36C25224N0197 is a delivery order under 36F79719D0169, a federal supply schedule, on Pharmaceuticals and Drugs (FSS-61-IB).

Was contract 36C25224N0197 competed?

The extent of competition for 36C25224N0197 was full and open competition. The government received 1 offer.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award